Funding
← Back to your selection

Sigmas Group

Activity from announced rounds

Activity in this selectionUnited States · Oct 9, 2026 · Jan 1, 2026
Rounds participated in
3
Confirmed lead rounds
0
2 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$212M
3 disclosed · full round size, not this investor’s share

By stage

Series A1
Series C+1
Undisclosed1

By primary sector

Biotech2
Defense tech1

By country

United States3

Rounds

3 in this selection
BigHat Biosciences

An AI and synthetic-biology platform that designs and engineers antibody therapeutics.

$75MSeries C
Participant
Scout AI

Develops AI foundation models that translate commander intent into coordinated unmanned system action

$100MSeries A
Role not disclosed
Centivax

Develops vaccines and therapies for universal protection against diverse targets

$37MUndisclosed
Role not disclosed